ENTA
Enanta Pharmaceuticals, Inc. [ENTA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ENTA Stock Summary
Top 10 Correlated ETFs
ENTA
Top 10 Correlated Stocks
ENTA
In the News
ENTA Financial details
Company Rating
-
Market Cap
348.02M
Income
-138.24M
Revenue
73.62M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
145
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-1.86
Forward P/E
-
PEG
-1.69
P/S
3.16
P/B
1.15
P/C
-
P/FCF
-2.23
Quick Ratio
6.52
Current Ratio
6.73
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-6.56
EPS next Y
-
EPS next Q
-
EPS this Y
7.95%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-17.34%
Revenue Q/Q
-4.91%
EPS Q/Q
18.8%
-
-
-
-
SMA20
10%
SMA50
37.5%
SMA100
57.14%
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-52%
ROC
-0.34%
Gross Margin
100%
Oper. Margin
-173%
Profit Margin
-169%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.08-38.79
52W High
-71.97%
52W Low
+33.13%
RSI
52
Rel Volume
3.85
Avg Volume
251.28K
Volume
967.71K
Perf Week
-3.27%
Perf Month
35.84%
Perf Quarter
102.09%
Perf Half Y
89.17%
-
-
-
-
Beta
0.488
-
-
Volatility
0.08%, 1.63%
Prev Close
1.72%
Price
10.65
Change
1.62%
Company Profile
- Volume Average 251.28K
- Market Capitalization 348.02M
- Employee 145
- CEO Dr. Jay R. Luly Ph.D.
- Headquarters Watertown,MA,US
- IPO Date 2013-03-21
-
Website
https://www.enanta.com 
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.
